IRES/subdominant epitope inhibitors (MERLIN Biotech)

N/A

Report date: 2025/06/11 10:27:50

Base Information

Drug NameIRES/subdominant epitope inhibitors (MERLIN Biotech)
Drug Alias Namechronic hepatitis B infection therapeutic vaccine (MERLIN Biotech)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerlin Biotech LLC
China Registration ClassN/A

Develop Information

Active CompaniesMerlin Biotech LLC
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A